Showing results (311-320 of 1,995) with videos related to
Sort By:
Pageof 200
Journal of Clinical Lipidology|February 16, 2022
Pharmacokinetics and pharmacodynamics of inclisiran, a small interfering RNA therapy, in patients with hepatic impairmentDavid Kallend, Robert Stoekenbroek, YanLing He, et al.Journal of Clinical Lipidology|May 4, 2019
JCL roundtable: Lipid treatment targetsDebra A Friedrich, Dean G Karalis, Karen E Aspry, et al.Journal of Clinical Lipidology|October 16, 2018
Diabetes is associated with an increased risk of cardiovascular disease in patients with familial hypercholesterolemiaMartine Paquette, Sophie Bernard, Isabelle Ruel, et al.Journal of Clinical Lipidology|February 8, 2022
Identification of a novel large duplication (exon2_6dup): copy number variation in the LDLR gene in a large family with familial hypercholesterolemia by whole-genome sequencingMika Hori, Atsushi Takahashi, Kiminori Hosoda, et al.Journal of Clinical Lipidology|April 5, 2022
Phenotypic and genotypic characterization of familial hypercholesterolemia in French adult and pediatric populationsMélanie Fourgeaud, Louis Lebreton, Khaldia Belabbas, et al.Journal of Clinical Lipidology|September 10, 2018
The prevalence, awareness, and treatment of lipid abnormalities in Iranian adults: Surveillance of risk factors of noncommunicable diseases in Iran 2016Zahra Aryan, Negar Mahmoudi, Ali Sheidaei, et al.Journal of Clinical Lipidology|August 31, 2018
MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissueEmilie Capel, Camille Vatier, Pascale Cervera, et al.Journal of Clinical Lipidology|September 12, 2018
Paradoxical fall in proteinuria during pregnancy in an LCAT-deficient patient-A case reportElinor V Hanna, Sara Simonelli, Sarah Chamney, et al.Journal of Clinical Lipidology|September 11, 2018
Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled studyJan Oscarsson, Kristina Önnerhag, Ulf Risérus, et al.Journal of Clinical Lipidology|October 6, 2018
Alirocumab dosing patterns during 40 months of open-label treatment in patients with heterozygous familial hypercholesterolemiaG Kees Hovingh, John R Guyton, Gisle Langslet, et al.Pageof 200